Skip to main content

Together we are beating cancer

Donate now

Cancer biology

Showing 12 out of 399 results

A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease. A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.

by Justine Alford | Analysis | 26 September 2017

26 September 2017

  • Science & Technology
  • Health & Medicine

SABR: radiotherapy that's smart, fast and to the point

Researchers believe that focused high doses of radiotherapy could one day replace surgery for small cancers in certain organs. Researchers believe that focused high doses of radiotherapy could one day replace surgery for small cancers in certain organs.

by Gabriella Beer | Analysis | 21 August 2017

21 August 2017

This entry is part 5 of 11 in the series Radiotherapy

Targeting healthy cells that have been hijacked by cancer cells could help treat many different types of the disease. Targeting healthy cells that have been hijacked by cancer cells could help treat many different types of the disease.

by Cancer Research UK | News | 3 August 2017

3 August 2017

New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t. New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.

by Justine Alford | Analysis | 27 June 2017

27 June 2017

This entry is part 2 of 23 in the series Science Surgery
Virtual reality

Step inside a virtual world where our Grand Challenge scientists are hoping to redefine the way we look at cancer. Step inside a virtual world where our Grand Challenge scientists are hoping to redefine the way we look at cancer.

by Nick Peel | Analysis | 2 May 2017

2 May 2017

Cancer Research UK logo

The first findings from the Cancer Research UK-funded TRACERx* lung cancer study show how tracking tumour evolution can help predict relapse. The first findings from the Cancer Research UK-funded TRACERx* lung cancer study show how tracking tumour evolution can help predict relapse.

by Cancer Research UK | News | 26 April 2017

26 April 2017